Dr. Miles Conrad is an interventional radiologist, a specialist in medical imaging who uses minimally invasive surgical techniques to treat patients with a wide variety of disorders including liver, lung and kidney cancer; venous disease; uterine fibrioids and trauma. He has extensive experience with hemodialysis interventions. Conrad also cares for patients with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder affecting the blood vessels, and he particularly focuses on treatment of pulmonary arteriovenous malformations (AVMs) and liver AVMs, tangles of blood vessels that may lead to serious problems such as stroke and heart failure. He treats children and adults. He is co-director of the UCSF Hereditary Hemorrhagic Telangiectasia Center, designated a center of excellence by Cure HHT, an organization dedicated to advancing understanding and treatment of the disease.
Conrad earned his medical degree from the Geisel School of Medicine at Dartmouth. He earned a master's degree in public health, with a specialty in quantitative methods, from the Harvard T.H. Chan School of Public Health. He completed a residency in diagnostic radiology from the University of Arizona, where he also completed a fellowship in interventional radiology.
Conrad is a member of the Society of Interventional Radiology and Physicians for Human Rights. He is also active in Cure HHT. He is passionate about health care equity and is devoted to closing the gap between the underserved and fully insured patients. He works at both Zuckerberg San Francisco General Hospital and at UCSF.